The hidden struggles of living with Lambert-Eaton myasthenic syndrome

Lambert-Eaton myasthenic syndrome (LEMS) is a rare condition affecting fewer than 3 million people globally. In the US, around 400 individuals live with the disorder, which often leads to muscle weakness, fatigue and long delays in diagnosis. Many also face hidden challenges, including mental health struggles and financial strain. LEMS causes weakness, dizziness and autonomic symptoms like dry mouth or blurred vision. For some, the condition increases fall risks, forcing them to limit daily activities. Diagnosis can take years due to its rarity and overlapping symptoms with other disorders.

About 60% to 70% of cases are linked to cancer, most commonly small cell lung cancer. Treatment often includes corticosteroids, which may ease muscle weakness but can disrupt sleep, worsen mood swings or, in rare cases, trigger severe reactions like psychosis. The impact extends beyond physical health. A 2024 survey found that roughly one in three people with LEMS experience anxiety or depression. Social isolation and financial hardship are also common, as many cannot maintain full-time work. Support groups offer a way to share experiences, while cognitive behavioural therapy (CBT) and medication can help manage mental health symptoms. Focusing on physical health—through strength exercises or symptom management—can also improve emotional wellbeing.

LEMS remains a complex condition with wide-ranging effects on daily life. While treatments and support networks exist, many still face delays in diagnosis and ongoing challenges with mobility, work and mental health. Early recognition and tailored care can help reduce some of these burdens.